Cargando…
Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163920/ http://dx.doi.org/10.1007/s40278-022-16507-y |
Ejemplares similares
-
Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
Publicado: (2020) -
Dexamethasone/prednisone/tofacitinib: COVID-19, thromboembolic episodes and off-label use: case report
Publicado: (2021) -
Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022) -
Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab: Depletion of B-lymphocytes, lack of efficacy and off label treatment: case report
Publicado: (2022) -
Hydroxychloroquine/mycophenolate mofetil/prednisone: SARS-CoV-2 infection: case report
Publicado: (2021)